• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Establishment of an In Vitro System of the Human Intestinal Microbiota: Effect of Cultivation Conditions and Influence of Three Donor Stool Samples.建立人体肠道微生物群的体外系统:培养条件的影响及三个供体粪便样本的作用
Microorganisms. 2021 May 13;9(5):1049. doi: 10.3390/microorganisms9051049.
2
Preservation by lyophilization of a human intestinal microbiota: influence of the cultivation pH on the drying outcome and re-establishment ability.冻干法保存人体肠道微生物群:培养 pH 值对干燥效果和重建能力的影响。
Microb Biotechnol. 2022 Mar;15(3):886-900. doi: 10.1111/1751-7915.14007. Epub 2022 Feb 6.
3
Distal colonic transit is linked to gut microbiota diversity and microbial fermentation in humans with slow colonic transit.远端结肠传输与肠道微生物多样性及微生物发酵有关,在结肠传输缓慢的人群中更是如此。
Am J Physiol Gastrointest Liver Physiol. 2020 Feb 1;318(2):G361-G369. doi: 10.1152/ajpgi.00283.2019. Epub 2019 Dec 23.
4
One dog's waste is another dog's wealth: A pilot study of fecal microbiota transplantation in dogs with acute hemorrhagic diarrhea syndrome.此狗之粪乃彼狗之财:急性出血性腹泻综合征犬粪便微生物群移植的一项初步研究。
PLoS One. 2021 Apr 19;16(4):e0250344. doi: 10.1371/journal.pone.0250344. eCollection 2021.
5
Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.与溃疡性结肠炎患者对粪便微生物群移植的反应相关的特定细菌和代谢物。
Gastroenterology. 2019 Apr;156(5):1440-1454.e2. doi: 10.1053/j.gastro.2018.12.001. Epub 2018 Dec 6.
6
High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria.高通量 DNA 序列分析揭示了先前冷冻粪便细菌移植后肠道微生物群的稳定定植。
Gut Microbes. 2013 Mar-Apr;4(2):125-35. doi: 10.4161/gmic.23571. Epub 2013 Jan 18.
7
Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.完全微生物群植入对于粪便微生物群移植后复发性艰难梭菌感染的恢复并非必不可少。
mBio. 2016 Dec 20;7(6):e01965-16. doi: 10.1128/mBio.01965-16.
8
Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.复发性艰难梭菌感染和/或溃疡性结肠炎患者单次供体粪便微生物群移植的纵向微生物组分析
PLoS One. 2018 Jan 31;13(1):e0190997. doi: 10.1371/journal.pone.0190997. eCollection 2018.
9
Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study.单一致病菌移植治疗复发性活动期溃疡性结肠炎的长期疗效和安全性:一项前瞻性随机试验研究。
Microb Cell Fact. 2021 Jan 19;20(1):18. doi: 10.1186/s12934-021-01513-6.
10
A comprehensive approach to stool donor screening for faecal microbiota transplantation in China.中国粪便微生物群移植中粪便供体筛查的综合方法。
Microb Cell Fact. 2021 Nov 27;20(1):216. doi: 10.1186/s12934-021-01705-0.

引用本文的文献

1
Ginseng extracts improve circadian clock gene expression and reduce inflammation directly and indirectly through gut microbiota and PI3K signaling pathway.人参提取物通过肠道微生物群和 PI3K 信号通路直接和间接改善生物钟基因表达并减少炎症。
NPJ Biofilms Microbiomes. 2024 Mar 19;10(1):24. doi: 10.1038/s41522-024-00498-5.
2
Preservation by lyophilization of a human intestinal microbiota: influence of the cultivation pH on the drying outcome and re-establishment ability.冻干法保存人体肠道微生物群:培养 pH 值对干燥效果和重建能力的影响。
Microb Biotechnol. 2022 Mar;15(3):886-900. doi: 10.1111/1751-7915.14007. Epub 2022 Feb 6.

本文引用的文献

1
Handling of spurious sequences affects the outcome of high-throughput 16S rRNA gene amplicon profiling.假序列的处理会影响高通量16S rRNA基因扩增子分析的结果。
ISME Commun. 2021 Jun 29;1(1):31. doi: 10.1038/s43705-021-00033-z.
2
Comparing Circadian Rhythmicity in the Human Gut Microbiome.比较人类肠道微生物组的昼夜节律性。
STAR Protoc. 2020 Oct 26;1(3):100148. doi: 10.1016/j.xpro.2020.100148. eCollection 2020 Dec 18.
3
An ecological framework to understand the efficacy of fecal microbiota transplantation.理解粪便微生物群移植疗效的生态框架。
Nat Commun. 2020 Jul 3;11(1):3329. doi: 10.1038/s41467-020-17180-x.
4
Arrhythmic Gut Microbiome Signatures Predict Risk of Type 2 Diabetes.肠道微生物组心律失常特征可预测 2 型糖尿病风险。
Cell Host Microbe. 2020 Aug 12;28(2):258-272.e6. doi: 10.1016/j.chom.2020.06.004. Epub 2020 Jul 2.
5
An in vitro model maintaining taxon-specific functional activities of the gut microbiome.一种维持肠道微生物组分类特有功能活性的体外模型。
Nat Commun. 2019 Sep 12;10(1):4146. doi: 10.1038/s41467-019-12087-8.
6
The microbiome, cancer, and cancer therapy.微生物组、癌症与癌症治疗。
Nat Med. 2019 Mar;25(3):377-388. doi: 10.1038/s41591-019-0377-7. Epub 2019 Mar 6.
7
Treatment and Prevention of Recurrent Clostridium difficile Infection with Functionalized Bovine Antibody-Enriched Whey in a Hamster Primary Infection Model.在仓鼠原发性感染模型中,用功能化牛抗体富集乳清治疗和预防复发性艰难梭菌感染。
Toxins (Basel). 2019 Feb 6;11(2):98. doi: 10.3390/toxins11020098.
8
Mechanistic Insights in the Success of Fecal Microbiota Transplants for the Treatment of Infections.粪便微生物群移植治疗感染成功的机制性见解
Front Microbiol. 2018 Jun 12;9:1242. doi: 10.3389/fmicb.2018.01242. eCollection 2018.
9
Microfluidic Organ-on-a-Chip Models of Human Intestine.人类肠道的微流控芯片器官模型
Cell Mol Gastroenterol Hepatol. 2018 Apr 24;5(4):659-668. doi: 10.1016/j.jcmgh.2017.12.010. eCollection 2018.
10
In vitro human colonic fermentation of indigestible fraction isolated from lunch menus: impact on the gut metabolites and antioxidant capacity.午餐菜单中不可消化部分的体外人体结肠发酵:对肠道代谢物和抗氧化能力的影响。
Int J Food Sci Nutr. 2018 Sep;69(6):718-728. doi: 10.1080/09637486.2017.1416458. Epub 2017 Dec 26.

建立人体肠道微生物群的体外系统:培养条件的影响及三个供体粪便样本的作用

Establishment of an In Vitro System of the Human Intestinal Microbiota: Effect of Cultivation Conditions and Influence of Three Donor Stool Samples.

作者信息

Haindl Regina, Engel Julia, Kulozik Ulrich

机构信息

Chair of Food and Bioprocess Engineering, ZIEL-Institute for Food & Health, Technical University of Munich, Weihenstephaner Berg 1, 85354 Freising, Germany.

出版信息

Microorganisms. 2021 May 13;9(5):1049. doi: 10.3390/microorganisms9051049.

DOI:10.3390/microorganisms9051049
PMID:34068085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8152740/
Abstract

Fecal microbiota transplantation (FMT) is an alternative method for the treatment of gastrointestinal diseases with a high recovery rate. Disadvantages are ethical concerns, high donor requirements and the low storability of stool samples. The cultivation of an in vitro microbiota in a continuous bioreactor was established as an alternative to FMT to overcome these problems. In this study, the influence of the system parameters and donor stool characteristics was investigated. Each continuous colonic fermentation system was inoculated with feces from three different donors until a stable state was established. The influence of the fermentation conditions on the system's behavior regarding cell count, metabolic activity, short-chain fatty acid profile and microbiota composition as well as richness and diversity was assessed. Cultivation conditions were found to affect the microbial system: the number of cells and the production of short-chain fatty acids increased. The abundance of Actinobacteria and Firmicutes decreased, Bacteroidetes increased, while Proteobacteria and Verrucomicrobia remained largely unaffected. Diversity in the in vitro system decreased, but richness was unaffected. The cultivation of stool from different donors revealed that the performance of the created in vitro system was similar and comparable, but unique characteristics of the composition of the original stool remained.

摘要

粪便微生物群移植(FMT)是一种治疗胃肠道疾病的替代方法,治愈率较高。其缺点包括伦理问题、对供体要求高以及粪便样本储存性差。建立在连续生物反应器中培养体外微生物群作为FMT的替代方法以克服这些问题。在本研究中,研究了系统参数和供体粪便特征的影响。每个连续结肠发酵系统接种来自三个不同供体的粪便,直至建立稳定状态。评估了发酵条件对系统在细胞计数、代谢活性、短链脂肪酸谱和微生物群组成以及丰富度和多样性方面行为的影响。发现培养条件会影响微生物系统:细胞数量和短链脂肪酸产量增加。放线菌和厚壁菌的丰度降低,拟杆菌增加,而变形菌和疣微菌基本不受影响。体外系统的多样性降低,但丰富度不受影响。对来自不同供体的粪便进行培养表明,所创建的体外系统的性能相似且具有可比性,但原始粪便组成的独特特征仍然存在。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f7/8152740/fc435dd5c47b/microorganisms-09-01049-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f7/8152740/1f97c996b14d/microorganisms-09-01049-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f7/8152740/694ab42af49e/microorganisms-09-01049-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f7/8152740/40d5ad591d97/microorganisms-09-01049-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f7/8152740/fc435dd5c47b/microorganisms-09-01049-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f7/8152740/1f97c996b14d/microorganisms-09-01049-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f7/8152740/694ab42af49e/microorganisms-09-01049-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f7/8152740/40d5ad591d97/microorganisms-09-01049-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45f7/8152740/fc435dd5c47b/microorganisms-09-01049-g004.jpg